Kun-Lin Yang
Papers
1
Total Citations
12
H-Index
1
About
Kun-Lin Yang is a surgical oncologist whose research focuses on advanced peritoneal metastases, particularly those arising from hepatocellular carcinoma (HCC). His most cited work investigates the efficacy of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for treating HCC peritoneal metastases—a condition with no established standard of care. This landmark study, with 12 citations, provides critical evidence that CRS/HIPEC may offer a viable treatment pathway for select patients, addressing a significant gap in oncologic surgery. Yang’s contributions are notable for tackling a challenging, under-researched clinical scenario, offering hope for improved outcomes in a patient population with limited options. His work underscores the potential of aggressive locoregional therapies in extending survival and refining surgical protocols. By systematically evaluating this combined approach, Yang has helped pave the way for future clinical trials and broader adoption of CRS/HIPEC in HCC management. His research continues to influence surgical decision-making and inspire further investigation into multimodal treatments for advanced peritoneal disease.
Research Focus
Key Achievements
Top Papers
- 1